{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:37:32Z","timestamp":1780472252367,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.autrev.2011.10.006","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T17:49:02Z","timestamp":1318614542000},"page":"288-295","source":"Crossref","is-referenced-by-count":64,"title":["Obstetric antiphospholipid syndrome"],"prefix":"10.1016","volume":"11","author":[{"given":"Claudio","family":"Galarza-Maldonado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Kourilovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar M.","family":"P\u00e9rez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gaybor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai F.","family":"Soroka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.10.006_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(00)00404-8","article-title":"Antiphospholipid syndrome and recurrent miscarriages","volume":"96","author":"Vinatier","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0010","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/humrep\/13.7.1975","article-title":"Mid-trimester loss \u2014 appraisal of a screening protocol","volume":"13","author":"Drakeley","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.autrev.2011.10.006_bb0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.006_bb0020","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.10.006_bb0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0028-1082270","article-title":"Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment","volume":"34","author":"Tincani","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.autrev.2011.10.006_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-007-0742-7","article-title":"The HELLP syndrome, antiphospholipid antibodies, and syndromes","volume":"27","author":"Asherson","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-008-8100-3","article-title":"Pregnancy and catastrophic antiphospholipid syndrome","volume":"36","author":"G\u00f3mez-Puerta","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.006_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2011.10.006_bb0050","series-title":"Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010","first-page":"158","volume":"20","author":"Branch","year":"2011"},{"key":"10.1016\/j.autrev.2011.10.006_bb0055","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1073\/pnas.88.8.3069","article-title":"Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies","volume":"88","author":"Blank","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2011.10.006_bb0060","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1172\/JCI115749","article-title":"Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)","volume":"89","author":"Bakimer","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.10.006_bb0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1191\/0961203303lu405oa","article-title":"The effects of antiphospholipid antibodies obtained from women with SLE\/APS and associated pregnancy loss on rat embryos and placental explants in culture","volume":"12","author":"Ornoy","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.006_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.54.101601.152412","article-title":"The antiphospholipid syndrome","volume":"54","author":"Rand","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.autrev.2011.10.006_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/03009742.1998.11720701","article-title":"Interleukin-3 and pregnancy loss in antiphospholipid syndrome","volume":"107","author":"Shoenfeld","year":"1998","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.autrev.2011.10.006_bb0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI115927","article-title":"Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H)","volume":"90","author":"Gharavi","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.10.006_bb0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0897.1997.tb00200.x","article-title":"Induction of experimental antiphospholipid antibody syndrome in PL\/J mice following immunization with beta 2 GPI","volume":"37","author":"Garcia","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0090","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.4049\/jimmunol.163.5.2922","article-title":"GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro","volume":"163","author":"Gharavi","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00001703-200404000-00006","article-title":"Antiphospholipid syndrome in pregnancy","volume":"16","author":"Carp","year":"2004","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9378(98)70277-7","article-title":"Placental pathology in systemic lupus erythematosus: a prospective study","volume":"179","author":"Magid","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2011.10.006_bb0105","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1177\/096120339800700218","article-title":"Placental pathology in antiphospholipid syndrome","volume":"7","author":"Levy","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.006_bb0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(81)92087-0","article-title":"Arterial thrombosis, intrauterine death and \u201clupus\u201d antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation","volume":"1","author":"Carreras","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2011.10.006_bb0115","first-page":"67","article-title":"Some antiphospholipid antibodies inhibit phospholipase A2 activity","volume":"120","author":"Schorer","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.autrev.2011.10.006_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0049-3848(93)90176-O","article-title":"Inhibition of heparin\/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis","volume":"71","author":"Chamley","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2011.10.006_bb0125","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJM198605013141817","article-title":"Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant","volume":"314","author":"Cariou","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.10.006_bb0130","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/0002-9378(94)90403-0","article-title":"Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion","volume":"171","author":"Rand","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0135","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1191\/0961203304lu2001oa","article-title":"Antiphospholipid antibodies as cause of pregnancy loss","volume":"13","author":"Meroni","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.006_bb0140","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1073\/pnas.90.14.6464","article-title":"Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation","volume":"90","author":"Sthoeger","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2011.10.006_bb0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","article-title":"Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I","volume":"43","author":"Di Simone","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.006_bb0150","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI0212337","article-title":"Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome","volume":"109","author":"Blank","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.10.006_bb0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3476(96)70274-3","article-title":"Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis","volume":"128","author":"Manco-Johnson","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2011.10.006_bb0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12016-008-8103-0","article-title":"Infections and the antiphospholipid syndrome","volume":"36","author":"Garc\u00eda-Carrasco","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11926-003-0030-8","article-title":"Antiphospholipid syndrome: genetic review","volume":"5","author":"Namjou","year":"2003","journal-title":"Curr Rheumatol Rep"},{"issue":"167","key":"10.1016\/j.autrev.2011.10.006_bb0170","first-page":"e1","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0175","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2011.10.006_bb0180","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.10.006_bb0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/A:1025321617304","article-title":"Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome","volume":"23","author":"Shoenfeld","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00003081-200103000-00003","article-title":"Mechanisms of pregnancy loss in antiphospholipid syndrome","volume":"44","author":"Gharavi","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/1464727992000199731","article-title":"Antiphospholipid antibodies and infertility","volume":"5","author":"Backos","year":"2002","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.autrev.2011.10.006_bb0200","first-page":"459","article-title":"Antiphospholipid syndrome updating","volume":"121","author":"Orts","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.autrev.2011.10.006_bb0205","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.thromres.2004.06.032","article-title":"An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay","volume":"114","author":"Levy","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2011.10.006_bb0210","series-title":"Trombosis en la pr\u00e1ctica cl\u00ednica","first-page":"113","article-title":"Anticuerpos antifosfol\u00edpidos","author":"Cervera","year":"2003"},{"key":"10.1016\/j.autrev.2011.10.006_bb0215","series-title":"Anticuerpos antifosfol\u00ecpidos y problemas de la reproducci\u00f3n","first-page":"43","article-title":"Pruebas de anticuerpos antifosfol\u00ecpidos: problemas y soluciones","author":"Piereangeli","year":"2001"},{"key":"10.1016\/j.autrev.2011.10.006_bb0220","series-title":"The antiphospholipid syndrome II-Autoimmune Thrombosis","first-page":"375","article-title":"Management of reproductive failure in the antiphospholipid syndrome","author":"Balasch","year":"2002"},{"key":"10.1016\/j.autrev.2011.10.006_bb0225","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2011.10.006_bb0230","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0235","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0240","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1378\/chest.119.1_suppl.122S","article-title":"Use of antithrombotic agents during pregnancy","volume":"119","author":"Ginsberg","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2011.10.006_bb0245","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/03009742.1998.11720789","article-title":"Corticosteroids during pregnancy","volume":"107","author":"Lockshin","year":"1998","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.autrev.2011.10.006_bb0250","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/art.20105","article-title":"Management of the obstetric antiphospholipid syndrome","volume":"50","author":"Derksen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.10.006_bb0255","first-page":"48","article-title":"S\u00edndrome antifosfolip\u00eddico: veinti\u00fan a\u00f1os despu\u00e9s","volume":"11","author":"Galarza-Maldonado","year":"2004","journal-title":"Rev Col Reumatol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0260","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0029-7844(03)00363-6","article-title":"Antiphospholipid syndrome: obstetric diagnosis, management, and controversies","volume":"101","author":"Branch","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0265","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0002-9378(89)90468-7","article-title":"Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody","volume":"160","author":"Lockshin","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2011.10.006_bb0270","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1191\/0961203303lu393oa","article-title":"Treatment of pregnant patients with antiphospholipid syndrome","volume":"12","author":"Tincani","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.10.006_bb0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","article-title":"TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss","volume":"174","author":"Berman","year":"2005","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T13:20:40Z","timestamp":1686403240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1568997211002138"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.10.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}